The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Trop. Dis
Sec. Neglected Tropical Diseases
Volume 5 - 2024 |
doi: 10.3389/fitd.2024.1391823
This article is part of the Research Topic Innovative Strategies in Drug Discovery for Drug-Resistant Tropical Diseases View all articles
Large-scale production of Mansonella perstans infective larvae from engorged Culicoides milnei
Provisionally accepted- 1 University of Buea, Buea, Cameroon
- 2 Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany
Background: Mansonella perstans is transmitted by Culicoides species and affects hundred millions of inhabitants in about 33 countries in sub-Saharan Africa. It is known that Mansonellosis due to Mansonella perstans do not result in a clear clinical picture, but down-regulates the immunity of patients predisposing them to other diseases like tuberculosis, HIV and malaria or damping vaccine efficacy. However, research about novel drugs against this filarial nematode is missing because of the lack of parasite material. Previous studies have developed in vitro culture systems using infective stage 3 larvae (L3), but these life stages are difficult to obtain and thus the performance of in vitro cultures is restricted and does not allow large-scale testing of drugs or even infection experiments in animal models. Therefore, we aim to establish a platform for the largescale production of M. perstans infective larvae from engorged Culicoides milnei.Methods: Culicoides species were caught in Yangom (Yabassi Health District) in the Littoral Region of Cameroon following a blood meal on six microfilariae-positive donors with different microfilaraemic loads over one year. Engorged midges were reared in the insectarium for up to 14 days and L3 were isolated from the different body parts.Result: In summary, 13,658 engorged Culicoides were collected and reared in the laboratory. We observed an overall predicted survival of 78.5%. Out of the 8,123 survived midges, 7,086 midges belong to C. milnei, from which 2,335 were infected leading to a recovery of 6,310 L3. Moreover, we found the highest survival rates of midges during the early dry season in December with moderate temperatures (23-25°C) and low (2-4mm) or no rainfall. In addition, we observed that midges that fed on donors with high microfilarial loads showed increased mortality.We revealed suitable conditions for the collection and maintenance of engorged Culicoides midges allowing the large-scale production of M. perstans L3. This procedure will provide a platform to produce sufficient parasite material that will facilitate in vitro cultures and the establishment of a murine model of M. perstans, which is important for in-depth investigation of the filarial biology and screening of novel drugs that are effective against this ivermectinresistant nematode.
Keywords: Mansonella perstans, infective stage 3 larvae (L3), Culicoides milnei, Midges, Vector abundance, survival and mortality of Culicoides species
Received: 26 Feb 2024; Accepted: 19 Nov 2024.
Copyright: © 2024 Chi, EBAI, Fombad, Esofi, Anna, Ouam, Gandjui, Valerine, Ekanya, Nietcho, Foyet, CHO, Magha, Njouendou, Enyong, Hoerauf, Ritter and Wanji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Manuel Ritter, Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, 53127, North Rhine-Westphalia, Germany
Samuel Wanji, University of Buea, Buea, Cameroon
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.